Last reviewed · How we verify
A Multi-Center Phase III Randomized, Controlled Study of Theratope Vaccine for Metastatic Breast Cancer
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Vaccines may make the body build an immune response to kill tumor cells. It is not yet known whether THERATOPE vaccine therapy is more effective than standard vaccine therapy in treating metastatic breast cancer. PURPOSE: Randomized double blinded phase III trial to compare the effectiveness of THERATOPE vaccine therapy with that of standard vaccine therapy in treating women who have metastatic breast cancer.
Details
| Lead sponsor | Oncothyreon Canada Inc. |
|---|---|
| Phase | Phase 3 |
| Status | COMPLETED |
| Enrolment | 950 |
| Start date | 1999-01 |
| Completion | 2008-12 |
Conditions
- Breast Cancer
Interventions
- Detox-B adjuvant
- THERATOPE STn-KLH vaccine
- keyhole limpet hemocyanin
- cyclophosphamide
Countries
Canada